PFS
RPRX icon

Prospera Financial Services’s Royalty Pharma RPRX Stock Holding History

Prospera Financial Services’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-196
Closed -$8K – 2398
2022
Q1 		$8K Buy
+196
New +$7.7K ﹤0.01% 2135

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return

Prospera Financial Services's RPRX Position: Q2 2022 in Review

Prospera Financial Services sold out of Royalty Pharma (RPRX) in Q2 2022, closing a stake of 196 shares — an estimated $8K sold.

Prospera Financial Services first reported a position in RPRX in Q1 2022 and held it in 1 quarter. The position peaked at $8K in Q1 2022. 283 funds tracked by Wall St. Rank hold RPRX as of Q2 2022.

  • Prospera Financial Services reported no remaining Royalty Pharma position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 196 Royalty Pharma shares in Q2 2022, an estimated $8K.
  • Prospera Financial Services first reported a position in Royalty Pharma in Q1 2022 and held it in 1 quarter.
  • Prospera Financial Services's Royalty Pharma position peaked at $8K in Q1 2022.
  • 283 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.